These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27132044)

  • 1. Serotonin transporter polymorphism alters citalopram effects on human pain responses to physical pain.
    Ma Y; Wang C; Luo S; Li B; Wager TD; Zhang W; Rao Y; Han S
    Neuroimage; 2016 Jul; 135():186-96. PubMed ID: 27132044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network.
    Ma Y; Li B; Wang C; Zhang W; Rao Y; Han S
    Br J Psychiatry; 2015 May; 206(5):385-92. PubMed ID: 25745133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderation of antidepressant response by the serotonin transporter gene.
    Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
    Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive effects of citalopram and serotonin transporter genotype on neural correlates of response inhibition and attentional orienting.
    Fischer AG; Endrass T; Goebel I; Reuter M; Montag C; Kubisch C; Ullsperger M
    Neuroimage; 2015 Aug; 116():59-67. PubMed ID: 25957993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
    Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
    Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
    Aragona M; Bancheri L; Perinelli D; Tarsitani L; Pizzimenti A; Conte A; Inghilleri M
    Eur J Pain; 2005 Feb; 9(1):33-8. PubMed ID: 15629872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in central serotonergic activity - relevance of the 5-HTTLPR, life events and their interaction.
    Wielpuetz C; Kuepper Y; Grant P; Munk AJ; Hennig J
    Behav Brain Res; 2015 Jan; 277():245-53. PubMed ID: 24374553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).
    Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G
    Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
    Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
    Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.
    Keers R; Uher R; Huezo-Diaz P; Smith R; Jaffee S; Rietschel M; Henigsberg N; Kozel D; Mors O; Maier W; Zobel A; Hauser J; Souery D; Placentino A; Larsen ER; Dmitrzak-Weglarz M; Gupta B; Hoda F; Craig I; McGuffin P; Farmer AE; Aitchison KJ
    Pharmacogenomics J; 2011 Apr; 11(2):138-45. PubMed ID: 20212518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5-HTTLPR-S/Lg polymorphisms.
    Ramasubbu R; Burgess A; Gaxiola-Valdez I; Cortese F; Clark D; Kemp A; Goodyear B; Macqueen G; Bech-Hansen NT; Foster J; Diwadkar VA
    Hum Psychopharmacol; 2016 Mar; 31(2):144-55. PubMed ID: 26879101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.
    Capozzo MA; Schillani G; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2009; 95(4):479-83. PubMed ID: 19856660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
    Rotberg B; Kronenberg S; Carmel M; Frisch A; Brent D; Zalsman G; Apter A; Weizman A
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):117-22. PubMed ID: 23510446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.
    Kilkens TO; Honig A; Fekkes D; Brummer RJ
    Aliment Pharmacol Ther; 2005 Nov; 22(9):865-74. PubMed ID: 16225497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study.
    Schrantee A; Solleveld MM; Schwantje H; Bruin WB; Mutsaerts HM; Adriaanse SM; Lucassen P; Booij J; Reneman L
    J Psychopharmacol; 2019 Jun; 33(6):660-669. PubMed ID: 30887865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.
    Garfield LD; Dixon D; Nowotny P; Lotrich FE; Pollock BG; Kristjansson SD; Doré PM; Lenze EJ
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):971-9. PubMed ID: 24021217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol and progesterone modify the effects of the serotonin reuptake transporter polymorphism on serotonergic responsivity to citalopram.
    Michopoulos V; Berga SL; Wilson ME
    Exp Clin Psychopharmacol; 2011 Dec; 19(6):401-8. PubMed ID: 21843009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.